Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen: May 30, 2007

Qiagen said this week that it has launched the first assays based on its QIAplex PCR multiplex technology, which enables the detection of multiple molecular targets in one test.
The ResPlex I Panel, ResPlex II Panel, and StaphPlex Panel allow parallel detection of more than ten bacterial and viral targets in a single reaction, the company said.
The ResPlex I Panel detects respiratory bacterial DNA, including DNA specific for Legionella pneumophila, Chlamydia pneumoniae, and Mycoplasma pneumoniae. ResPlex II detects respiratory viral RNA from influenza and parainfluenza viruses, RSV, metapneumovirus, and rhinoviruses. The StaphPlex Panel identifies methicillin-resistant Staphylococcus aureus DNA.
All three panels are available for research use only.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.